Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PRKCA | P17252 | 3/20 | 0.39 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.39 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13224338 | 0.94 | DGKA (0.48) | TSHRDGKACYP1A2PRKCAPRKCE | |
| SCHEMBL29231823 | 0.91 | DGKA (0.52) | TSHRDGKACYP1A2PRKCAPRKCE | |
| SCHEMBL2177185 | 0.89 | TSHR (0.56) | TSHRCYP1A2PAMLMNAKMT2A | |
| SCHEMBL27684698 | 0.88 | CAMK2A (0.46) | TSHRDGKACYP1A2PRKCAPRKCE | |
| SCHEMBL36646 | 0.88 | — | — | |
| SCHEMBL1815437 | 0.87 | ADRA2A (0.43) | TSHRDGKACYP1A2PRKCAPRKCE | |
| Ammonia Solution, Strong SCHEMBL11819014 | 0.86 | CAMK2A (0.43) | TSHRDGKACYP1A2PRKCAPRKCE | |
| SCHEMBL5665374 | 0.86 | CAMK2A (0.43) | TSHRDGKACYP1A2PRKCAPRKCE | |
| SCHEMBL4638331 | 0.86 | CAMK2A (0.43) | TSHRDGKACYP1A2PRKCAPRKCE | |
| SCHEMBL117077 | 0.86 | GPR84 (0.46) | DGKACYP1A2PRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115073615-A | Construction method of artificial organelles capable of improving catalysis efficiency of cell factory | 大连理工大学 | 2022-09-20 | — | — | CN | claimed |
| CN-114280189-B | Method for quickly and quantitatively analyzing fermentation metabolites of microbial cell factory | 大连理工大学 | 2022-09-09 | — | — | CN | claimed |
| CN-114561312-B | Recombinant yeast for synthesizing ursolic acid and construction method thereof | 北京理工大学 | 2022-08-09 | — | — | CN | claimed |
| CN-114561312-A | Recombinant yeast for synthesizing ursolic acid and construction method thereof | 北京理工大学 | 2022-05-31 | — | — | CN | claimed |
| CN-112795495-B | Method for producing heterologous cannabichromene by using saccharomyces cerevisiae | 大连理工大学 | 2021-10-26 | — | — | CN | claimed |
| CN-112795495-A | Method for producing heterologous cannabichromene by using saccharomyces cerevisiae | 大连理工大学 | 2021-05-14 | — | — | CN | claimed |
| US-RE40837-E1 | Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2009-07-07 | — | — | US | claimed |
| US-20080009449-A1 | Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis | SASKATCHEWAN, UNIVERSITY OF (CA) | 2008-01-10 | — | — | US | claimed |
| US-6673773-B2 | ADMINISTERING COMPLEX HAVING PURITY OF AT LEAST 95% DERIVED FROM FLAXSEED AND CONTAINING SECOISOLARICIRESINOL DIGLUCOSIDE, CINNAMIC ACID GLUCOSIDES AND HYDROXYMETHYL GLUTARIC ACID | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INCORPORATED (CA) | 2004-01-06 | — | — | US | claimed |
| US-20030212007-A1 | LIGNAN COMPLEX DERIVED FROM FLAXSEED AS HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROTIC AGENT | UNIVERSITY OF SASKATCHEWAN (CA) | 2003-11-13 | — | — | US | claimed |
| CN-122038157-A | Engineering bacteria and method for synthesizing lacrimal alcohol | 天津凯莱英生物科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119020170-B | Monascus purpureus and application of selenium-enriched monascus prepared by same | 西北大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-119269659-A | Application of urine organic acid in health management | 欧湧淳 | 2025-01-07 | — | — | CN | disclosed |
| CN-119020170-A | Monascus purpureus and application of selenium-enriched monascus prepared by same | 西北大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-118726121-A | Recombinant pichia pastoris strain, construction method and application thereof | 中国科学院大连化学物理研究所 | 2024-10-01 | — | — | CN | disclosed |
| US-5274088-A | Reduction of 16-oxo-26-phthalimidochloesterol | NEW YORK UNIVERSITY (US) | 1993-12-28 | — | — | US | disclosed |
| EP-0393180-B1 | 26-AMINOCHOLESTEROL AND DERIVATIVES AND ANALOGS THEREOF IN THE REGULATION OF CHOLESTEROL ACCUMULATION IN BODY TISSUE | UNIV NEW YORK (US) | 1993-12-15 | — | — | EP | disclosed |
| US-4939134-A | 26-aminocholesterol and derivatives and analogs thereof in the regulation of cholesterol accumulation in body tissue | NEW YORK UNIVERSITY (US) | 1990-07-03 | — | — | US | disclosed |
| US-4470981-A | STEROIDS, LOWERING SERUM CHOLESTEROL | HESSE ROBERT H | 1984-09-11 | — | — | US | disclosed |
| US-4427668-A | 26-Hydroxycholesterol and derivatives and analogs thereof in regulation of cholesterol accumulation in body tissue | NEW YORK UNIVERSITY (US) | 1984-01-24 | — | — | US | disclosed |